Project Surveys

M-CERSI is interested in better understanding how clinicians currently use, and have historically used, certain bulk drug substances nominated for use in compounding by outsourcing facilities under section 503B of the Federal Food, Drug, and Cosmetic Act.

We want to understand how medical practitioners prescribe and administer compounded drugs. Your feedback will help the Food and Drug Administration (FDA) develop a list of drugs that can be used in bulk compounding by 503B outsourcing facilities. Your anonymous responses will be shared with the FDA as part our of our project, "Clinical Use of Drugs Including Bulk Drug Substances Nominated for Use in Compounding by Outsourcing Facilities."

The time required to complete this survey is approximately 10-15 minutes. Click or tap on the link below to search for substances by name or specialty.

• Substances by Name
• Substances by Specialty

If you would like to tell us more about your use of compounded products, contact us at compounding@rx.umaryland.edu. Thank you for your participation.

Substances by Name:

The table below contains an alphabetical list of all of the substances for which we are collecting survey responses at this time. Click or tap on the substance name to access the relevant survey.

Substances by Specialty:

Click or tap on the specialties listed below to access the surveys for substances most relevant to a particular field.